ELEV Stock Forecast & Price Target
ELEV Stock
Price Forecast
The average stock forecast for
Elevation Oncology Inc (ELEV) in the next 12 months is 1.52 USD. This price target corresponds to an upside
of
317.31%. The range of stock forecasts for ELEV is 0.36 - 7.35 USD.
Based on the ratings of 14 analysts, the consensus recommendation for ELEV is
HOLD.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
0.36 |
1.52 |
0.38 |
7.35 |
| Upside |
-0.38% |
317.31% |
3.40% |
1,913.70% |
Recommendation Trends
The latest consensus rating for ELEV is "HOLD". This is the average
recommendation of 14 analysts: 0 strong sell,
0 sell, 8 hold, 3 buy, 3 strong buy. In the previous period, 14 analysts also majorly recommmended
"HOLD" for ELEV.
ELEV Financial Stock
Forecast
Revenue This Year
from -M
Revenue Next Year
from -M